Strategy

Jul 14, 2015
Pharmaceutical Executive
Our annual Pharma 50 listing is clear proof that once-small and midsize biopharma companies are joining the top ranks of big Pharma.
Jul 07, 2015
Sarah Chaney gives an in-depth look at the Salix-Valeant acquisition — how analysts and investors can affect decision-making and potentially drive poor behavior.
May 20, 2015
Pharm Exec talks to Matt Wallach, President of upstart start-up, Veeva Systems
May 05, 2015
Meike Wenzel and Clifford Hall examine a new concept for early commercialization planning to facilitate good cross-functional working practice.
Apr 23, 2015
Mike Straw offers four key changes to address the "lack of love" for pharmaceutical procurement functions.
Apr 22, 2015
Successful outsourcing can provide pharma companies with high-value, cost-effective analytics. But there are challenges, write Ram Moorthy and Dharmendra Sahay.
Apr 21, 2015
The need for proactive pharmacovigilance is being increasingly acknowledged by all companies, regardless of their size and product mix, writes Dr. Chitra Lele.
Mar 11, 2015
Pharmaceutical Executive
Pharm Exec recently convened a roundtable discussion with nine company aspirants for leadership in the hard science of small biotech.
Mar 07, 2015
Adam Sherlock looks at why pharma companies have started taking regulatory information management (RIM) more seriously.
Jan 29, 2015
What's hot and what's not this year? Is pharma still a 21st century growth industry? See our 2015 Strategic Outlook.
native1_300x100
lorem ipsum